Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127184772 | 12718477 | 2 | F | 20160807 | 20160913 | 20160906 | 20160922 | EXP | FR-PFIZER INC-2016410257 | PFIZER | 91.00 | YR | M | Y | 0.00000 | 20160922 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127184772 | 12718477 | 1 | PS | TAHOR | ATORVASTATIN CALCIUM | 1 | Oral | 10 MG, 1X/DAY | Y | 20702 | 10 | MG | FILM-COATED TABLET | QD | |||||
| 127184772 | 12718477 | 2 | SS | PAROXETINE HYDROCHLORIDE. | PAROXETINE HYDROCHLORIDE | 1 | Oral | 20 MG, 1X/DAY IN THE MORNING | 60 | MG | Y | 0 | 20 | MG | FILM-COATED TABLET | QD | |||
| 127184772 | 12718477 | 3 | SS | PAROXETINE HYDROCHLORIDE. | PAROXETINE HYDROCHLORIDE | 1 | 60 | MG | Y | 0 | FILM-COATED TABLET | ||||||||
| 127184772 | 12718477 | 4 | SS | LASILIX FAIBLE | FUROSEMIDE | 1 | Oral | 20 MG, 1X/DAY IN THE MORNING | Y | 0 | 20 | MG | TABLET | QD | |||||
| 127184772 | 12718477 | 5 | SS | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | Oral | 20 MG, 1X/DAY | Y | 0 | 20 | MG | QD | ||||||
| 127184772 | 12718477 | 6 | C | PARACETAMOL | ACETAMINOPHEN | 1 | Oral | 1 G, AS NEEDED | 0 | 1 | G | ||||||||
| 127184772 | 12718477 | 7 | C | SPAGULAX | PLANTAGO OVATA SEED | 1 | 1 SACHET THREE TIMES DAILY | 0 | 1 | DF | TID | ||||||||
| 127184772 | 12718477 | 8 | C | ISPAGHULA EXTRACTPSYLLIUM | PLANTAGO OVATA SEEDPLANTAGO SEED | 1 | 1 SACHET THREE TIMES DAILY | 0 | 1 | DF | TID | ||||||||
| 127184772 | 12718477 | 9 | C | PLAVIX | CLOPIDOGREL BISULFATE | 1 | Oral | 75 MG, 1X/DAY IN THE MORNING | 0 | 75 | MG | FILM-COATED TABLET | QD | ||||||
| 127184772 | 12718477 | 10 | C | FORLAX | POLYETHYLENE GLYCOL 4000 | 1 | 1-2 SACHETS IN THE MORNING | 0 | 1 | DF | QD | ||||||||
| 127184772 | 12718477 | 11 | C | SERESTA | OXAZEPAM | 1 | Oral | 10 MG, 1X/DAY IN THE MORNING | 0 | 10 | MG | TABLET | QD | ||||||
| 127184772 | 12718477 | 12 | C | KARDEGIC | ASPIRIN LYSINE | 1 | Oral | 75 MG, 1X/DAY AT NOON | 0 | 75 | MG | POWDER FOR ORAL SOLUTION | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127184772 | 12718477 | 1 | Cardiovascular disorder |
| 127184772 | 12718477 | 2 | Depressed mood |
| 127184772 | 12718477 | 3 | Weight decreased |
| 127184772 | 12718477 | 4 | Hypertension |
| 127184772 | 12718477 | 5 | Gastrooesophageal reflux disease |
| 127184772 | 12718477 | 6 | Pain |
| 127184772 | 12718477 | 7 | Constipation |
| 127184772 | 12718477 | 8 | Constipation |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127184772 | 12718477 | OT |
| 127184772 | 12718477 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127184772 | 12718477 | Constipation | |
| 127184772 | 12718477 | Fall | |
| 127184772 | 12718477 | Hyponatraemia | |
| 127184772 | 12718477 | Inappropriate antidiuretic hormone secretion | |
| 127184772 | 12718477 | Pancreatic steatosis | |
| 127184772 | 12718477 | Renal impairment |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127184772 | 12718477 | 1 | 20160818 | 0 | ||
| 127184772 | 12718477 | 2 | 20160806 | 20160809 | 0 | |
| 127184772 | 12718477 | 4 | 20160809 | 0 | ||
| 127184772 | 12718477 | 5 | 20160809 | 0 | ||
| 127184772 | 12718477 | 9 | 201604 | 0 | ||
| 127184772 | 12718477 | 12 | 201604 | 0 |